Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Enrolling by invitation Phase 3 Interventional

Open-Label Safety Study of Solriamfetol in Subjects With Binge Eating Disorder

ClinicalTrials.gov ID: NCT06878976

Public ClinicalTrials.gov record NCT06878976. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 4:48 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Study to Assess the Long-term Safety and Efficacy of Solriamfetol in Adults With Binge Eating Disorder

Study identification

NCT ID
NCT06878976
Recruitment status
Enrolling by invitation
Study type
Interventional
Phase
Phase 3
Lead sponsor
Axsome Therapeutics, Inc.
Industry
Enrollment
300 participants

Conditions and interventions

Interventions

  • Solriamfetol 75mg, 150 mg, or 300 mg Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 56 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 19, 2025
Primary completion
Nov 30, 2026
Completion
Nov 30, 2026
Last update posted
Nov 24, 2025

2025 – 2026

United States locations

U.S. sites
31
U.S. states
15
U.S. cities
29
Facility City State ZIP Site status
Clinical Research Site Encino California 91316
Clinical Research Site Long Beach California 90806
Clinical Research Site Santa Ana California 92705
Clinical Research Site Walnut Creek California 94596
Clinical Research Site West Covina California 91790
Clinical Research Site Cromwell Connecticut 06416
Clinical Research Site Fort Myers Florida 33912
Clinical Research Site Hialeah Florida 33012
Clinical Research Site Jacksonville Florida 32256
Clinical Research Site Lauderhill Florida 33319
Clinical Research Site Miami Florida 33145
Clinical Research Site Miami Florida 33176
Clinical Research Site Orlando Florida 32801
Clinical Research Site Marietta Georgia 30060
Clinical Research Site Overland Park Kansas 66210
Clinical Research Site Boston Massachusetts 02131
Clinical Research Site Saint Charles Missouri 63304
Clinical Research Site Cherry Hill New Jersey 08002
Clinical Research Site Mount Kisco New York 10549
Clinical Research Site New York New York 10128
Clinical Research Site Raleigh North Carolina 27607
Clinical Research Site Cincinnati Ohio 45215
Clinical Research Site Mason Ohio 45040
Clinical Research Site North Canton Ohio 44720
Clinical Research Site Portland Oregon 97210
Clinical Research Site North Charleston South Carolina 29405
Clinical Research Site Memphis Tennessee 38119
Clinical Research Site Austin Texas 78731
Clinical Research Site Austin Texas 78737
Clinical Research Site Dallas Texas 75251
Clinical Research Site San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06878976, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 24, 2025 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06878976 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →